Mason Taylor

Chercheur en biotechnologie 🧬 | Passionné d'IA 🤖 | Amateur de tennis et de randonnée 🌲 | Lecteur de science-fiction 📚

[HCPLive @HCPLiveNews]

Why does vitiligo take longer to respond than psoriasis or atopic dermatitis? Iltefat Hamzavi, MD, explains in part 2 of his #EADV2026 interview on the phase 3 Tranquillo data:

https://t.co/83nfOvtzKP

[Cleveland Clinic MD @CleClinicMD]

Our surgeons have developed a new protocol to treat the abdominal and perineovaginal areas as a unified single surgical field during laparoscopic or robotic gynecological procedures: https://t.co/fpsUR2LIEy

[John Cumbers @johncumbers]

Every cheap RNA screen in drug discovery throws away the thing that splice-switching drugs actually change. @Sculpta just went after that.

Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬
https://t.co/zNAM5BPJT0

@neal_amin left a Stanford faculty position to build this. The chemistry is elegant. Plant handles along the RNA inside living cells, click a DNA barcode onto them, and pool every sample before a single enzyme gets involved.

Two approved drugs already work by fixing how one gene is spliced. Imagine screening for the next ones with isoform resolution as standard.

"We are working towards the first comprehensive atlas of RNA processing at single cell resolution for new therapeutic target discovery."

Visit the SynBioBeta website to read the full article.
https://t.co/xVc8qZn0Ne

[Helen Branswell 🇨🇦 @HelenBranswell]

The confirmed #measles count in Pennsylvania has topped 1,000. Important to note that confirmed cases make up only a portion of all cases, especially given infections among PA's Amish community probably do not come to public health's attention in many cases. https://t.co/tzRMFIZuMm

[good papers @paperperday]

Breaking the Degeneracy of Sense Codons – How Far Can We Go?

"towards a future where the 64 codons can encode more than 30 monomers"
https://t.co/RoKj2eOo4W

[sciqst @sciqst]

@urotoday @zklaassen_md @GACancerCenter @l_ballas @CedarsSinai The key question is whether pausing improves first-pass placement accuracy or just resident confidence. Curious if you tracked both separately across the ~250 cases? I’d be tempted to have sciqst generate a review on simulation-based procedural training.

[MRehMan @_Wienman_]

Been collecting some preprints of the last while and made a short list of my favorites.

It's become more and more that there just sooo many papers being released, it's getting harder to digest them all.

Absolutely check these ones out, there one where I'm still thinking about them days afterwards or least give some hope to the future of science

1. "pH-sensitive binder design with Proton-PottsMPNN” — Sergey Ovchinnikov and collaborators
@sokrypton

2. “Firewalled synthetic commensal blocks horizontal gene transfer in the gut” — Akos Nyerges lab
@AkosNyerges

3.“De novo design of allosterically controlled enzymes” — David Baker group
@thedmbaker

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

This framework aims to support outcome selection, consistency across trials, comparison of interventions, and evaluation of disease-modifying strategies in type 2 #diabetes https://t.co/zy6cyB0Ahb
#T2D #disease #modification #outcomes

[HCPLive @HCPLiveNews]

Can a once-daily oral peptide keep scalp, genital, hand/foot, and nail psoriasis clear for 2 years?

See what the new ICONIC-TOTAL data on icotrokinra showed at #EADV2026:

https://t.co/dCKmI2IT23

[Genetic Engineering & Biotechnology News @GENbio]

Autism Target Discovered in Endothelial Cells in Genetic Deletion Mouse Model

Study in adult mice showed that targeting P2Y2 could reverse behavioral symptoms that were already well established
@OttawaHospital @uOttawa
#autismspectrumdisorder #brain
https://t.co/XMvVTi09pE

[sciqst @sciqst]

@DrJayMohan Wondering whether the partial deployment was apparent before withdrawal, or only after the sheath jammed? Curious if device-position checks could reliably catch this earlier. sciqst.

[Drug Discovery World @DDWJournal]

Women leading in biopharma: Charlotte Edenius, Gesynta

https://t.co/z857SrjrW2

Follow DDW; Business insights for the global scientific community
#Biopharma

[Dr. Datta M.D. (Radiology) building CRASHLab.in @DrDatta_AIIMS]

Thank you to my friend @HealthcareAIGuy for the feature and honoured to be a passenger on The ElevAItor Ride, his #AIinHealthcare newsletter, on the day it turns one year old. Coincidentally, I myself turned a year older yesterday!

Three things I talk about:

1. The promise on how AI could finally take high-quality care to the last mile, to rural India and other LMICs.

2. The peril of models flooding healthcare with big claims and little evidence and how this could widen inequity.

3. The path towards trusting any AI tool before use by asking two simple questions: Has it been tested on people like me? Has it been tested in my language?

Congratulations on a year of building this global conversation!

@CRASHLabAI @KCDH_A

[Katarzyna Kakareko @kponikwicka]

1/3 AI in PD research — where are we now, and where could we go next?
Yeoungjee Cho did fantastic job of taking us through the gaps, and the potential role of AI in moving PD research forward.
#ISPD26 #ISPDEearlyCareer #PeritonealDialysis @ISPDCongress @ISPD1

[Elad Asher @AsherElad]

Authors: luminal gain and multiple fractures before stenting predict expansion, and lithotripsy delivers both.

The predictor analysis is observational inside a randomized trial, and the abstract reports no confidence intervals.

DOI 10.1016/j.ijcard.2026.134941
#OCT

[Drug Discovery World @DDWJournal]

FDA approves obinutuzumab for rare autoimmune disease

https://t.co/sCbxVwmUtw

Follow DDW; Business insights for the global scientific community
#AutoimmuneDisease

[EURETINA @EURETINA]

Discover the #Euretina26 Exhibition!

Explore cutting-edge tech, breakthrough treatments, and the latest in retina care, all in one place. Network with industry leaders and get inspired for your next innovation.

Full exhibitor list: https://t.co/834JVkjXYS

#Ophthalmology

[Physician's Weekly @physicianswkly]

🫀 Food Is Medicine changes trajectories, not just meals.

Dr. Eberly (@eberly_lauren @PennCardiology @IHSgov) shares how an #FIM program with medically & culturally tailored meals cut hospitalizations & #ED visits for HF patients across #Navajo Nation👉️https://t.co/g33WOiH2uj

[HCPLive @HCPLiveNews]

In case you missed it: a new pooled CUPID A/C analysis found dupilumab improved quality of life in omalizumab-naive CSU patients at Week 24.💡

Here's what the data showed: https://t.co/ifLQteApb0

#EADV

[Insilico Medicine @InSilicoMeds]

Ready to see how Agentic AI is transforming drug discovery? 💻

Our software team at Insilico Medicine has been hard at work behind the scenes preparing an insightful session, and we’re excited to welcome our community in just a few hours.

Join us live as we dive into real-world applications, agentic workflows, and the future of AI-driven therapeutics.

🗓️ Beginning this morning at 10:00 AM ET

🔗 Register: https://t.co/x2HD5oYd3G

#PharmaAI2026 #PharmaAIEvents